Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: Antibiotics; Breast Cancer; Diabetes; Asthma
The spread of antibiotic resistance, where infectious bacteria are able to defeat the drugs intended to kill them, may not be primarily driven by antibiotic consumption, according to a new study. (eLife, 2/14)
Limited level 1 evidence is available on the omission of radiotherapy after breast-conserving surgery in older women with hormone receptor–positive early breast cancer receiving adjuvant endocrine therapy. (Kunkler, M.D., et al, 2/16)
A pair of new studies conclude that, compared with their never-infected peers, COVID-19 Omicron survivors may be at a 60% or greater risk of new-onset type 1 or 2 diabetes, a potential precursor of heart attack and stroke. (Van Beusekom, 2/14)
People with asthma in Hong Kong experienced worse control of their asthma after they had recovered from mild to moderate COVID-19, according to findings yesterday in Respiratory Research. For the case-control study, researchers with the University of Hong Kong enrolled 111 people with asthma who had experienced mild to moderate COVID-19 from 30 to 270 days before enrollment and 110 asthma patients who hadn't had COVID. (Wappes, 2/15)
